Category: NEWS

Procrit and Aranesp: CMS Denies Reimbursement with New Policy

Comments

The Centers for Medicare & Medicaid Services (CMS) recently implemented a change in the coverage of two necessary drugs used in conjunction with the treatment of cancer. Procrit and Aranesp are given to cancer patients who suffer from anemia due to low red blood cell counts as a result of chemotherapy. These drugs have been used successfully in accordance with current Federal Drug Administration (FDA) regulations in relieving the fatigue…

Read More

Neltner Billing Now Has Oncology Benchmark Data

Comments

Neltner Billing and Consulting has recently created oncology benchmark data that are based on financial analyses of 13 oncology practices across the country. This may be a helpful comparison for your practice. Results of the analyses are illustrated below. The first graph compares the breakdown of total charges in the 13 practices. Click here to download. The second graph compares physician services versus infusion in the 13 practices. Click here…

Read More

Neltner Billing and Consulting Creates “Neltner Health Care Advocacy Alliance”

Comments

Neltner Billing and Consulting Creates “Neltner Healthcare Advocacy Alliance” Healthcare in the United States today is facing many challenges that are putting our overall system at risk. Neltner understands the issues. We want to help. So, we’ve started a new subsidiary – the “Neltner Healthcare Advocacy Alliance” – an organization to create awareness about these healthcare challenges through education and grassroots activities. Our long-term goal is to help reduce overall…

Read More